Early seizure frequency and aetiology predict long-term medical outcome in childhood-onset epilepsy

Brain

Volumn 132, Issue 4, 2009, Pages 989-998

  Sillanp, Matti ^a   Schmidt, Dieter ^b  

^a UNIVERSITY OF TURKU   (Finland)

^b Epilepsy Research Group   (Germany)

Author keywords

Childhood; Epilepsy prognosis; Epileptology; Mortality; Seizures

Indexed keywords

ACETAZOLAMIDE; ANTICONVULSIVE AGENT; ETHOSUXIMIDE; MESUXIMIDE; METHYLPHENOBARBITAL; PHENOBARBITAL; PHENYTOIN; PRIMIDONE; TRIETHYLOXAZOLIDINE; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; ARTICLE; CHILD; CLINICAL FEATURE; CONTROLLED STUDY; DRUG DOSE COMPARISON; EPILEPSY; FEMALE; FOLLOW UP; HUMAN; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MORTALITY; OUTCOME ASSESSMENT; POPULATION RESEARCH; PRESCHOOL CHILD; PRIORITY JOURNAL; REMISSION; RISK ASSESSMENT; SCHOOL CHILD; SEIZURE;

ADOLESCENT; AGE OF ONSET; ANTICONVULSANTS; CHILD; CHILD, PRESCHOOL; DRUG RESISTANCE; EPIDEMIOLOGIC METHODS; EPILEPSY; FEMALE; FINLAND; HUMANS; INFANT; MALE; PROGNOSIS; REMISSION INDUCTION; TREATMENT OUTCOME;

EID: 65249103938     PISSN: 00068950     EISSN: 14602156     Source Type: Journal    
DOI: 10.1093/brain/awn357     Document Type: Article

References (44)

1. Annegers JF, Hauser WA, Elveback LR. Remission of seizures and relapse in patients with epilepsy. Epilepsia 1979; 20: 729-37.
2. Berg AT, Levy SR, Novotny EJ, Shinnar S. Predictors of intractable epilepsy in childhood: a case-control study. Epilepsia 1996; 37: 24-30.
3. Berg AT, Shinnar D, Levy SR, et al. Early development of intractable epilepsy in children: a prospective study. Neurology 2001; 56: 1445-52.
4. Berg AT, Shinnar S, Testa FM, Levy SR, Smith SN, Beckerman B. Mortality in childhood-onset epilepsy. Arch Pediatr Adolesc Med 2004; 158: 1147-52.
5. Bertol V, Oliveros A, Gros MB, Brieva L. Valor prognostico de los datos clinicaos, EEG y neuroimagen en la epilepsia con crisos parciales come-plejas. Rev Neurol 1999; 24: 964-8.
6. Callenbach PM, Westendorp RG, Geerts AT, Arts WF, Peeters EA, van Donselaar CA, et al. Mortality risk in children with epilepsy: the Dutch study of epilepsy in childhood. Pediatrics 2001; 107: 1259-63.
7. Camfield P, Camfield C. Childhood epilepsy: what is the evidence for what we think and what we do? Child Neurol 2003; 18: 272-87.
8. Camfield CS, Camfield PR, Veugelers PJ. Death in children with epilepsy: a population-based study. Lancet 2002; 359: 1891-95.
9. Casetta I, Granieri E, Monetti VC, Gilli G, Tola MR, Paolini E, et al. Early predictors of intractability in childhood epilepsy: a community-based case-control study in Copparo, Italy. Acta Neurol Scand 1999; 99: 329-33.
10. Central Statistical Office of Finland, 1989. Classification of socio-economic groups. Helsinki, Finland: Central Statistical Office of Finland; 1989. p. 1-53 (In Finnish).
11. Cockerell OC, Johnson AL, Sander JW, Hart YM, Shorvon SD. Remission of epilepsy: results from the National General Practice Study of Epilepsy. Lancet 1995; 346: 140-4.
12. Cockerell OC, Johnson AL, Sander JW, Hart YM, Shorvon SD. Prognosis of epilepsy: a review and further analysis of the first nine years of the British National General Practice Study of Epilepsy, a prospective, population-based study. Epilepsia 1997; 38: 31-46.
13. Commission on Classification and Terminology of the International League Against Epilepsy. Proposal for revised clinical and electroence-phalographic classification of epileptic seizures. Epilepsia 1981; 22: 489-501.
14. Commission on Epidemiology and Prognosis, International League Against Epilepsy Guidelines for epidemiologic studies on epilepsy. Epilepsia 1993; 34: 592-6.
15. Dulac O, Leppik IE, Chadwick DW, Specchio L. Starting and stopping treatment. In: Engel J Jr, Pedley TA (eds). Epilepsy. A comprehensive textbook. Philadelphia: Wolters-Kluver-Lippincott Williams & Wilkins; 2007. p. 1301-9.
16. French JA, Kanner AM, Bautista J, Abou-Khalil B, Browne T, Harden CL, et al. Efficacy and tolerability of the new antiepileptic drugs, I: treatment of refractory epilepsy: Report of the TTA and QSS Subcommittees of the American Academy of Neurology ad the American Epilepsy Society. Epilepsia 2004; 45: 410-23.
17. Gururaj A, Sztriha L, Hertecant J, Eapen V. Clinical predictors of intractable childhood epilepsy. J Psychosom Res 2006; 61: 343-7.
18. Janz D. Die Epilepsien. Stuttgart: Thieme; 1969. p. 456.
19. Ko T-S, Holmes GL. EEG and clinical predictors of medically intractable childhood epilepsy. Clin Neurophysiol 1999; 110: 1245-51.
20. Kurtz Z, Tookey P, Ross E. Epilepsy in young people: 23-year follow-up of the British National Child Development Study. Br Med J 1998; 316: 339-42.
21. Kwong KL, Sung WY, Wong SN, So WT. Early predictors of medical intractability in childhood epilepsy. Pediatr Neurol 2003; 29: 46-52.
22. Langfitt JT, Wiebe S. Early surgical treatment for epilepsy. Curr Opin Neurol 2008; 2: 179-83.
23. Loiseau P, Jallon P. Epilepsies pharmacoresistantes de l'adulte. Revue Neurologique (Paris) 1995; 151: 295-306.
24. Luciano AL, Shorvon SD. Results of treatment changes in patients with apparently drug-resistant chronic epilepsy. Ann Neurol 2007; 62: 375-81.
25. MacDonald BK, Johnson AL, Goodridge DM, Cockerell OC, Sander JW, Shorvon SD, et al. Factors predicting prognosis of epilepsy after presentation with seizures. Ann Neurol 2000; 48: 833-41.
26. Nashef L. Sudden unexpected death in epilepsy: terminology and definitions. Epilepsia 1997; 38 (Suppl 11): S6-8.
27. Oskoui M, Webster RI, Zhang X, Shevell MI. Factors predictive of outcome in childhood epilepsy. J Child Neurol 2005; 20: 898-904.
28. Picot MC, Baldy-Moulinier M, Daurès J-P, Dujols P, Crespel A. The prevalence of epilepsy and pharmacoresistant epilepsy in adults. A population-based study in a Western European country. Epilepsia 2008; 49: 1230-8.
29. SAS Institute Inc. SAS System for windows release 9.1.3. Cary, NC: SAS Institute; 2003.
30. Schiller Y, Najjar Y. Quantifying the response to antiepileptic drugs: effect of past treatment history. Neurology 2008; 70: 54-65.
31. Schmidt D, Lö scher W. Drug resistance in epilepsy: putative neurobiolo-gic and clinical mechanisms. Epilepsia 2005; 46: 858-77.
32. Sillanpää M. Remission of seizures and predictors of intractability in long-term follow-up. Epilepsia 1993; 34: 930-6.
33. Sillanpää M, Camfield PR, Camfield CS. Predicting long-term outcome of childhood epilepsy in Nova Scotia, Canada, and Turku, Finland: validation of a simple scoring system. Arch Neurol 1995; 52: 589-92.
34. Sillanpää M, Haataja L, Shinnar S. Perceived impact of childhood-onset epilepsy on quality of life as an adult. Epilepsia 2004; 45: 971-7.
35. Sillanpää M, Jalava M, Kaleva O, Shinnar S. Long-term prognosis of seizures with onset in childhood. N Engl J Med 1998; 338: 1715-22.
36. Sillanpää M, Jalava M, Shinnar S. Epilepsy syndromes in patients with childhood-onset seizures in Finland. Pediatr Neurol 1999; 21: 533-7.
37. Sillanpää M, Schmidt D. Natural history of treated childhood-onset epilepsy: prospective, long-term population-based study. Brain 2006; 129: 617-24.
38. Sillanpää M, Schmidt D. Seizure clustering during drug treatment affects seizure outcome and mortality of childhood-onset epilepsy. Brain 2008; 131: 938-44.
39. Sillanpää M, Shinnar S. Status epilepticus in a population-based cohort with childhood-onset epilepsy in Finland. Ann Neurol 2002; 52: 303-10.
40. Spooner CG, Berkovic SF, Mitchell LA, Wrennall JA, Harvey AS. New-onset temporal lobe epilepsy in children: lesion on MRI predicts poor seizure outcome. Neurology 2006; 67: 2117-8.
41. Strauss DJ, Day SM, Shavelle RM, Wu YW. Remote symptomatic epilepsy. Does seizure severity increase mortality? Neurology 2003; 60: 395-9.
42. Trinka E, Martin F, Luef G, Unterberger I, Bauer G. Chronic epilepsy with complex partial seizures is not always medically intractable-a long-term observational study. Acta Neurol Scand 2001; 103: 219-25.
43. Wang Z, Qi L, Song X. Prognosis and preditive factors of partial seizures in children. Pediatr Neurol 2007; 37: 16-20.
44. Wiebe S, Blume WT, Girvin JP, Eliasziw M, Effectiveness and Efficacy of Surgery for Temporal Lobe Epilepsy Study Group. A randomized, controlled trial of surgery for temporal-lobe epilepsy. N Engl J Med 2001; 345: 311-18.